Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2016 马来西亚耐药性结核病的管理指南（第1版）

2016-12-01 马来西亚卫生部 马来西亚卫生部官网

耐药性结核病管理指南

本文的主要目的是为安全有效的管理耐药结核病患者提供循证建议，内容包括：耐药性结核的预防，有效控制耐多药结核框架，病例登记和治疗结果定义，发现病例策略，实验室检查，治疗策略，特殊人群的治疗，启动治疗及治疗监测，副作用管理等。

中文标题：

2016 马来西亚耐药性结核病的管理指南（第1版）

英文标题：

CLINICAL PRACTICE GUIDELINES: MANAGENT OF DRUG RESISTANT TUBERCULOSIS(1ST EDITION)

发布机构：

马来西亚卫生部

发布日期：

2016-12-01

简要介绍：

本文的主要目的是为安全有效的管理耐药结核病患者提供循证建议，内容包括：耐药性结核的预防，有效控制耐多药结核框架，病例登记和治疗结果定义，发现病例策略，实验室检查，治疗策略，特殊人群的治疗，启动治疗及治疗监测，副作用管理等。


拓展指南：与结核病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 马来西亚耐药性结核病的管理指南（第1版）)] GetToolGuiderByIdResponse(projectId=1, id=2de951c001a55309, title=2016 马来西亚耐药性结核病的管理指南（第1版）, enTitle=CLINICAL PRACTICE GUIDELINES: MANAGENT OF DRUG RESISTANT TUBERCULOSIS(1ST EDITION), guiderFrom=马来西亚卫生部官网, authorId=null, author=, summary=本文的主要目的是为安全有效的管理耐药结核病患者提供循证建议，内容包括：耐药性结核的预防，有效控制耐多药结核框架，病例登记和治疗结果定义，发现病例策略，实验室检查，治疗策略，特殊人群的治疗，启动治疗及治疗监测，副作用管理等。, cover=, journalId=null, articlesId=null, associationId=525, associationName=马来西亚卫生部, associationIntro=马来西亚卫生部是马来西亚的政府机构，负责本国卫生行政管理。, copyright=0, guiderPublishedTime=Thu Dec 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=本文的主要目的是为安全有效的管理耐药结核病患者提供循证建议，内容包括：耐药性结核的预防，有效控制耐多药结核框架，病例登记和治疗结果定义，发现病例策略，实验室检查，治疗策略，特殊人群的治疗，启动治疗及治疗监测，副作用管理等。 <div><br> </div> 拓展指南：<strong>与<font color=red>结核病</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=708ff1c001a014e3" title="【世界防治结核病日，你该知道的事】结核病相关指南最新中文版大放送!!!" target=_blank>【世界防治结核病日，你该知道的事】结核病相关指南最新中文版大放送!!!</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=198641c001a00e78" title="国家结核病规划指南—儿童结核病管理第2版" target=_blank>国家结核病规划指南—儿童结核病管理第2版</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=a31b11c001a00596" title="2016意大利儿童耐药结核病治疗推荐" target=_blank>2016意大利儿童耐药结核病治疗推荐</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=8d33d1c001a00058" title="解读肿瘤坏死因子拮抗剂应用中结核病的预防与管理专家共识" target=_blank>解读肿瘤坏死因子拮抗剂应用中结核病的预防与管理专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=4b1ff1c001399e2d" title="2016新加坡临床指南：结核病的预防、诊断及管理（中文版）" target=_blank>2016新加坡临床指南：结核病的预防、诊断及管理（中文版）</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E7%BB%93%E6%A0%B8%E7%97%85" target=_blank>有关结核病更多指南</a></ul>, tagList=[TagDto(tagId=1476, tagName=耐药性), TagDto(tagId=380, tagName=结核病), TagDto(tagId=4059, tagName=管理), TagDto(tagId=63, tagName=指南)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=34, categoryName=全科医学, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3139, appHits=71, showAppHits=0, pcHits=2034, showPcHits=1394, likes=135, shares=1, comments=3, approvalStatus=1, publishedTime=Fri Jun 16 09:18:38 CST 2017, publishedTimeString=2016-12-01, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri Jun 16 09:18:38 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 08:31:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 马来西亚耐药性结核病的管理指南（第1版）)])
2016 马来西亚耐药性结核病的管理指南（第1版）
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=357594, encodeId=c43c35e594a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/6f80f6d18bfb74ecb66b6ced313da725.jpg, createdBy=61d639722, createdName=wuqianhong99, createdTime=Tue Jan 08 21:35:22 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213535, encodeId=888c21353501, content=学习了，分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Wed Jun 21 16:20:45 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211881, encodeId=aef72118813d, content=先学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK7d6S14DhpWpoRXy8EsJ0JFT942eIBM2CSLggTQholicCzYqW0eP3qLx5Od4Ig2icBEj9RKdXcrZFA/0, createdBy=91ea83165, createdName=angel1005, createdTime=Sat Jun 17 10:16:05 CST 2017, time=2017-06-17, status=1, ipAttribution=)]
    2019-01-08 wuqianhong99

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=357594, encodeId=c43c35e594a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/6f80f6d18bfb74ecb66b6ced313da725.jpg, createdBy=61d639722, createdName=wuqianhong99, createdTime=Tue Jan 08 21:35:22 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213535, encodeId=888c21353501, content=学习了，分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Wed Jun 21 16:20:45 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211881, encodeId=aef72118813d, content=先学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK7d6S14DhpWpoRXy8EsJ0JFT942eIBM2CSLggTQholicCzYqW0eP3qLx5Od4Ig2icBEj9RKdXcrZFA/0, createdBy=91ea83165, createdName=angel1005, createdTime=Sat Jun 17 10:16:05 CST 2017, time=2017-06-17, status=1, ipAttribution=)]
    2017-06-21 杨利洪

    学习了，分享了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=357594, encodeId=c43c35e594a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/6f80f6d18bfb74ecb66b6ced313da725.jpg, createdBy=61d639722, createdName=wuqianhong99, createdTime=Tue Jan 08 21:35:22 CST 2019, time=2019-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213535, encodeId=888c21353501, content=学习了，分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Wed Jun 21 16:20:45 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211881, encodeId=aef72118813d, content=先学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK7d6S14DhpWpoRXy8EsJ0JFT942eIBM2CSLggTQholicCzYqW0eP3qLx5Od4Ig2icBEj9RKdXcrZFA/0, createdBy=91ea83165, createdName=angel1005, createdTime=Sat Jun 17 10:16:05 CST 2017, time=2017-06-17, status=1, ipAttribution=)]
    2017-06-17 angel1005

    先学习一下

    0

Baidu
map
Baidu
map
Baidu
map